Concepts (112)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Down Syndrome | 8 | 2020 | 120 | 1.890 |
Why?
|
Central Nervous System Stimulants | 5 | 2022 | 221 | 1.180 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 4 | 2022 | 189 | 1.080 |
Why?
|
Autism Spectrum Disorder | 3 | 2022 | 111 | 0.910 |
Why?
|
Attention Deficit and Disruptive Behavior Disorders | 1 | 2019 | 29 | 0.680 |
Why?
|
Adrenergic alpha-Agonists | 1 | 2019 | 57 | 0.680 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2020 | 34 | 0.680 |
Why?
|
Treatment Refusal | 1 | 2019 | 40 | 0.660 |
Why?
|
Child, Preschool | 13 | 2022 | 3187 | 0.620 |
Why?
|
Intellectual Disability | 1 | 2019 | 114 | 0.610 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 772 | 0.490 |
Why?
|
Sleep Apnea Syndromes | 1 | 2015 | 40 | 0.480 |
Why?
|
Sleep Apnea, Obstructive | 4 | 2017 | 142 | 0.480 |
Why?
|
Developmental Disabilities | 2 | 2012 | 119 | 0.480 |
Why?
|
Tonsillectomy | 4 | 2017 | 69 | 0.440 |
Why?
|
Methylphenidate | 3 | 2021 | 97 | 0.430 |
Why?
|
Child Behavior Disorders | 1 | 2012 | 69 | 0.410 |
Why?
|
Parents | 2 | 2019 | 312 | 0.400 |
Why?
|
Mass Screening | 3 | 2012 | 843 | 0.390 |
Why?
|
Child | 12 | 2022 | 6405 | 0.350 |
Why?
|
Adenoidectomy | 3 | 2017 | 51 | 0.320 |
Why?
|
Child Development | 1 | 2009 | 102 | 0.320 |
Why?
|
Parenting | 1 | 2009 | 91 | 0.310 |
Why?
|
Exosomes | 2 | 2019 | 44 | 0.300 |
Why?
|
Adolescent | 10 | 2020 | 8912 | 0.270 |
Why?
|
Health Status | 1 | 2009 | 429 | 0.270 |
Why?
|
Infant | 6 | 2020 | 2891 | 0.250 |
Why?
|
Cross-Sectional Studies | 3 | 2019 | 2279 | 0.240 |
Why?
|
Comorbidity | 2 | 2020 | 1426 | 0.220 |
Why?
|
Retrospective Studies | 5 | 2022 | 7277 | 0.200 |
Why?
|
Depression | 1 | 2009 | 943 | 0.200 |
Why?
|
Humans | 18 | 2022 | 68618 | 0.200 |
Why?
|
Guanfacine | 1 | 2021 | 6 | 0.190 |
Why?
|
Adrenergic alpha-2 Receptor Agonists | 1 | 2021 | 11 | 0.190 |
Why?
|
Sleep Wake Disorders | 1 | 2022 | 94 | 0.190 |
Why?
|
Male | 12 | 2021 | 37321 | 0.190 |
Why?
|
Female | 12 | 2021 | 38074 | 0.190 |
Why?
|
Electronic Health Records | 2 | 2021 | 374 | 0.170 |
Why?
|
Protective Devices | 1 | 2019 | 13 | 0.170 |
Why?
|
Extracellular Vesicles | 1 | 2019 | 21 | 0.170 |
Why?
|
Amphetamine | 1 | 2019 | 77 | 0.170 |
Why?
|
Communication Disorders | 1 | 2019 | 12 | 0.170 |
Why?
|
Endocytosis | 1 | 2019 | 113 | 0.160 |
Why?
|
Insurance, Health | 1 | 2019 | 201 | 0.150 |
Why?
|
Societies, Medical | 1 | 2020 | 403 | 0.150 |
Why?
|
Medicaid | 1 | 2019 | 302 | 0.140 |
Why?
|
Pediatrics | 1 | 2020 | 341 | 0.140 |
Why?
|
Weight Gain | 1 | 2017 | 135 | 0.140 |
Why?
|
Schools | 2 | 2021 | 156 | 0.130 |
Why?
|
Sleep Apnea, Central | 1 | 2015 | 6 | 0.130 |
Why?
|
Hypoventilation | 1 | 2015 | 8 | 0.130 |
Why?
|
Facial Bones | 1 | 2015 | 10 | 0.130 |
Why?
|
Practice Patterns, Physicians' | 1 | 2019 | 504 | 0.120 |
Why?
|
Age Factors | 1 | 2019 | 1864 | 0.120 |
Why?
|
Pharynx | 1 | 2015 | 89 | 0.120 |
Why?
|
South Carolina | 1 | 2020 | 2752 | 0.110 |
Why?
|
Risk Assessment | 1 | 2019 | 2007 | 0.110 |
Why?
|
Early Diagnosis | 1 | 2012 | 122 | 0.100 |
Why?
|
Physicians, Primary Care | 1 | 2012 | 46 | 0.100 |
Why?
|
Cognition Disorders | 1 | 2015 | 342 | 0.100 |
Why?
|
United States | 3 | 2019 | 7367 | 0.100 |
Why?
|
Alzheimer Disease | 1 | 2016 | 565 | 0.100 |
Why?
|
Attention | 1 | 2012 | 225 | 0.090 |
Why?
|
Psychometrics | 1 | 2012 | 514 | 0.090 |
Why?
|
Evidence-Based Practice | 1 | 2011 | 146 | 0.080 |
Why?
|
Residence Characteristics | 1 | 2011 | 252 | 0.080 |
Why?
|
Parent-Child Relations | 1 | 2009 | 98 | 0.080 |
Why?
|
Infant, Newborn | 2 | 2017 | 2455 | 0.080 |
Why?
|
Anemia, Sickle Cell | 1 | 2012 | 364 | 0.080 |
Why?
|
Obesity | 1 | 2015 | 1076 | 0.070 |
Why?
|
Health Promotion | 1 | 2011 | 407 | 0.070 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2009 | 782 | 0.070 |
Why?
|
Postoperative Period | 2 | 2017 | 238 | 0.070 |
Why?
|
Young Adult | 4 | 2017 | 5717 | 0.070 |
Why?
|
Logistic Models | 1 | 2009 | 1420 | 0.060 |
Why?
|
Irritable Mood | 1 | 2021 | 15 | 0.050 |
Why?
|
Medication Therapy Management | 1 | 2021 | 32 | 0.050 |
Why?
|
Disorders of Excessive Somnolence | 1 | 2021 | 28 | 0.050 |
Why?
|
Telephone | 1 | 2021 | 160 | 0.050 |
Why?
|
Educational Status | 1 | 2021 | 273 | 0.050 |
Why?
|
Adult | 2 | 2017 | 21403 | 0.040 |
Why?
|
Feeding and Eating Disorders | 1 | 2021 | 106 | 0.040 |
Why?
|
Cell Communication | 1 | 2019 | 116 | 0.040 |
Why?
|
Palate | 1 | 2017 | 14 | 0.040 |
Why?
|
Tongue | 1 | 2017 | 20 | 0.040 |
Why?
|
Tracheostomy | 1 | 2017 | 31 | 0.040 |
Why?
|
Postoperative Hemorrhage | 1 | 2017 | 69 | 0.040 |
Why?
|
Polysomnography | 1 | 2017 | 92 | 0.030 |
Why?
|
tau Proteins | 1 | 2016 | 61 | 0.030 |
Why?
|
Amyloid beta-Peptides | 1 | 2016 | 191 | 0.030 |
Why?
|
Combined Modality Therapy | 1 | 2017 | 951 | 0.030 |
Why?
|
Peptide Fragments | 1 | 2016 | 483 | 0.030 |
Why?
|
Body Mass Index | 1 | 2017 | 867 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2017 | 7029 | 0.030 |
Why?
|
Reaction Time | 1 | 2012 | 170 | 0.020 |
Why?
|
Hospitalization | 1 | 2017 | 978 | 0.020 |
Why?
|
Cohort Studies | 1 | 2017 | 2358 | 0.020 |
Why?
|
Healthy People Programs | 1 | 2011 | 13 | 0.020 |
Why?
|
Biomarkers | 1 | 2016 | 1593 | 0.020 |
Why?
|
Fragile X Syndrome | 1 | 2010 | 17 | 0.020 |
Why?
|
Smoking Prevention | 1 | 2011 | 259 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2010 | 320 | 0.020 |
Why?
|
Middle Aged | 2 | 2017 | 21147 | 0.020 |
Why?
|
Cognition | 1 | 2012 | 513 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2012 | 1738 | 0.020 |
Why?
|
Pilot Projects | 1 | 2012 | 1342 | 0.020 |
Why?
|
Wounds and Injuries | 1 | 2011 | 334 | 0.020 |
Why?
|
Diet | 1 | 2011 | 514 | 0.020 |
Why?
|
Exercise | 1 | 2011 | 658 | 0.020 |
Why?
|
Animals | 1 | 2019 | 20881 | 0.010 |
Why?
|
Substance-Related Disorders | 1 | 2011 | 1242 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2010 | 2223 | 0.010 |
Why?
|